ATG2B and breast carcinoma: Moreover, lower expression levels of ATG2B and c-Kit mRNA were significantly associated with worse breast cancer recurrence-free survival (RFS) and OS (all log-rank p <0.001; Supplementary Figures S1D, F, G, I).